Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rachel Shtainfeld"'
Autor:
Oren Pleniceanu, Racheli Shukrun, Dorit Omer, Einav Vax, Itamar Kanter, Klaudyna Dziedzic, Naomi Pode‐Shakked, Michal Mark‐Daniei, Sara Pri‐Chen, Yehudit Gnatek, Hadas Alfandary, Nira Varda‐Bloom, Dekel D Bar‐Lev, Naomi Bollag, Rachel Shtainfeld, Leah Armon, Achia Urbach, Tomer Kalisky, Arnon Nagler, Orit Harari‐Steinberg, Jack L Arbiser, Benjamin Dekel
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 4, Pp 508-530 (2017)
Abstract Angiomyolipoma (AML), the most common benign renal tumor, can result in severe morbidity from hemorrhage and renal failure. While mTORC1 activation is involved in its growth, mTORC1 inhibitors fail to eradicate AML, highlighting the need for
Externí odkaz:
https://doaj.org/article/04ce0232c4284454b179f5026fd0dc37
Autor:
Nira Varda-Bloom, Dorit Omer, Naomi Pode-Shakked, Orit Harari-Steinberg, Leah Armon, Hadas Alfandary, Rachel Shtainfeld, Klaudyna Dziedzic, Oren Pleniceanu, Michal Mark-Daniei, Yehudit Gnatek, Sara Pri-Chen, Arnon Nagler, Tomer Kalisky, Naomi Bollag, Einav Vax, Itamar Kanter, Dekel D. Bar-Lev, Benjamin Dekel, Achia Urbach, Racheli Shukrun, Jack L. Arbiser
Publikováno v:
EMBO Molecular Medicine
Angiomyolipoma (AML), the most common benign renal tumor, can result in severe morbidity from hemorrhage and renal failure. While mTORC1 activation is involved in its growth, mTORC1 inhibitors fail to eradicate AML, highlighting the need for new ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a12dfb79181c69949538946aa27406
https://doi.org/10.15252/emmm.201506111
https://doi.org/10.15252/emmm.201506111